Delivery Order SPE2DR25D9231-SPE2DR26FHPE8
Award Date 4/2/26
Potential Completion Date 4/23/26
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,328.08 delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for Avastin 100 mg/4 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Avastin 100 mg/4 ml vial pharmaceutical product with a ceiling value of $4,656.16. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), DLA's indefinite delivery contract vehicle supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business headquartered...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for Avastin 400 mg/16 ml vials with a ceiling value of $8,992.55. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling through December 31, 2036. The PPV-G GEN V contract authorizes DLA to issue firm fixed-price delivery orders...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Avastin 100 mg/4 ml vials, with a ceiling value of $2,328.08 and an ultimate completion date of March 23, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order is priced on a firm fixed-price...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Avastin 400 mg/16 mL vials with a ceiling value of $8,709.44. This delivery order, awarded on July 24, 2025, represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $4,010.09 to DMS Pharmaceutical Group Inc. for the supply of Avastin 100 mg/4 mL vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a single shipment of this oncology medication to support military healthcare requirements. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,250.56 contract was awarded by the Defense Logistics Agency (DLA) on July 11, 2023 and has an ultimate completion date of August 1, 2023. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the...
- The Defense Logistics Agency awarded a delivery order valued at $17,418.88 to DMS Pharmaceutical Group Inc. for Avastin 400 mg/16 ml vials on September 8, 2025, with completion expected by September 29, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Avastin is a branded bevacizumab product used in oncology treatment, reflecting the Defense Logistics Agency's ongoing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,721.84 firm fixed-price delivery order is for the supply of Avastin (bevacizumab) 400 mg/16 mL vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a delivery order valued at $2,291.48 to DMS Pharmaceutical Group Inc. for the supply of Avastin 100 mg/4 mL vials on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside...